Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-26-059121
Filing Date
2026-08-26
Accepted
2026-08-26 17:23:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 14148
  Complete submission text file 0001628280-26-059121.txt   15960
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Subject) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39062 | Film No.: 261324121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Opportunity Fund II, L.P. (Reporting) CIK: 0001885327 (see all company filings)

EIN.: 872809161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144